CEACAM5 and cancer: During the screening visit, after the patient provided the Informed Consent Form, the patient was interviewed, the wound was assessed, physical examinations were performed, BMI was determined, blood was collected to determine glycated haemoglobin, general morphology, Enthyrocyte Sedimentation Rate, cholesterol, Prostate Specific Antigen (PSA), Cancer Antigen 125 markers (CA 125), Carcino-Embryonic Antigen (CEA), Cancer Antigen 19-9 (CA 19-9), creatinine, Aspartrate Aminostransferase (AST), and Alanine Aminotransferase (ALT).